PR Newswire
HEERLEN, Netherlands, Aug. 4, 2020
HEERLEN, Netherlands, Aug. 4, 2020 /PRNewswire/ --
H1 Highlights1
Key figures and indicators
in € million | H1 2020 | H1 2019 | % Change | Volume | Price/mix | FX | Other |
Sales | 4,532 | 4,568 | -1% | -1% | -1% | 0% | 1% |
Nutrition | 3,224 | 3,029 | 6% | 5% | 0% | -1% | 2% |
Materials | 1,194 | 1,427 | -16% | -14% | -3% | 1% | 0% |
Adjusted EBITDA | 825 | 862 | -4% | | | | |
Nutrition | 674 | 639 | 5% | | | | |
Materials | 189 | 262 | -28% | | | | |
Innovation | 11 | 11 | | | | | |
Corporate | -49 | -50 | | | | | |
EBITDA | 746 | 823 | | | | | |
Adjusted EBITDA margin | 18.2% | 18.9% | | | | | |
| |||||||
(1) Adjusted EBITDA is an Alternative Performance Measure (APM) that reflects continuing operations. | |||||||
Organic sales growth is the total impact of volume and price/mix. | |||||||
Adjusted Net Operating Free Cash Flow is the cash flow from operating activities, corrected for the cash flow of |
Co-CEOs statement
Geraldine Matchett and Dimitri de Vreeze, Co-CEOs, commented: "Our teams continued to successfully navigate the challenging global environment, with Q2 developments in line with the expectations we set out in May. Business conditions for Nutrition were good overall in the first half, with spikes in demand for Animal Nutrition in Q1 and Human Nutrition in Q2 as end-markets reacted in response to COVID-19. Trading conditions in Materials deteriorated abruptly at the end of Q1 as customers' operations and end user demand were impacted by COVID-19, with these effects continuing throughout Q2.
Having taken early actions to limit capital expenditure and minimize operating costs in Materials, we have now also initiated the next phase of our profit improvement actions aimed at delivering annualized recurring savings of €25-30 million.
Early in the year we launched the Fit for Growth program in Nutrition. The new organizational structure, which enables a more differentiated go-to-market approach, is in place and we are now working on further building out our specialty business. Our recent acquisitions all add to our specialty solutions offerings, accelerating our growth strategy.
The global human impact of the COVID-19 pandemic is a clear lesson and therefore we have joined several of the 'Build Back Better' initiatives. As a purpose-led organization, we believe it is more important than ever for the world to commit to a more sustainable, fair and resilient future."
Q2 Highlights
Key figures and indicators
in € million | Q2 2020 | Q2 2019 | % Change | Volume | Price/mix | FX | Other |
Sales | 2,239 | 2,276 | -2% | -2% | 0% | -1% | 1% |
Nutrition | 1,649 | 1,512 | 9% | 6% | 3% | -2% | 2% |
Materials Werbung Mehr Nachrichten zur Koninklijke DSM Aktie kostenlos abonnieren
E-Mail-Adresse
Bitte überprüfe deine die E-Mail-Adresse.
Benachrichtigungen von ARIVA.DE (Mit der Bestellung akzeptierst du die Datenschutzhinweise) -1 Vielen Dank, dass du dich für unseren Newsletter angemeldet hast. Du erhältst in Kürze eine E-Mail mit einem Aktivierungslink. Hinweis: ARIVA.DE veröffentlicht in dieser Rubrik Analysen, Kolumnen und Nachrichten aus verschiedenen Quellen. Die ARIVA.DE AG ist nicht verantwortlich für Inhalte, die erkennbar von Dritten in den „News“-Bereich dieser Webseite eingestellt worden sind, und macht sich diese nicht zu Eigen. Diese Inhalte sind insbesondere durch eine entsprechende „von“-Kennzeichnung unterhalb der Artikelüberschrift und/oder durch den Link „Um den vollständigen Artikel zu lesen, klicken Sie bitte hier.“ erkennbar; verantwortlich für diese Inhalte ist allein der genannte Dritte. Andere Nutzer interessierten sich auch für folgende News |